BCL9 and breast carcinoma: We thus were motivated to investigate the specific contribution of Bcl9 and Bcl9L to β-catenin-mediated Wnt signaling and as a consequence to tumor progression in the MMTV-PyMT transgenic mouse model of breast cancer.